127 related articles for article (PubMed ID: 53656)
1. Treatment of osteoporosis of ageing with 1alpha-hydroxycholecalciferol.
Lund B; Hjorth L; Kjaer I; Reimann I; Friis T; Andersen RB; Sorensen OH
Lancet; 1975 Dec; 2(7946):1168-71. PubMed ID: 53656
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1alpha-hydroxycholecalciferol in senile osteoporosis and in bone loss following prednisone treatment.
Sorensen OH; Lund B; Friis TH; Hjorth L; Reimann I; Kjaer I; Andersen RB
Isr J Med Sci; 1977 Mar; 13(3):253-8. PubMed ID: 852974
[TBL] [Abstract][Full Text] [Related]
3. Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.
Tougaard L; Sorensen E; Brochner-Mortensen J; Christensen MS; Rodbro P; Sorensen AW
Lancet; 1976 May; 1(7968):1044-7. PubMed ID: 57451
[TBL] [Abstract][Full Text] [Related]
4. 1alpha-hydroxycholecalciferol. Long-term treatment of patients with uraemic osteodystrophy.
Nielsen SP; Binderup E; Godtfredsen WO; Jensen H; Ladefoged J
Nephron; 1976; 16(5):359-70. PubMed ID: 1264309
[TBL] [Abstract][Full Text] [Related]
5. Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.
Kanis JA; Henderson RG; Heynen G; Ledingham JG; Russell RG; Smith R; Walton RJ
Arch Dis Child; 1977 Jun; 52(6):473-81. PubMed ID: 879833
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral and calcium metabolism before, during and after treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S
Scand J Rheumatol; 1982; 11(1):55-7. PubMed ID: 7063813
[TBL] [Abstract][Full Text] [Related]
7. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
8. Treatment of senile osteoporosis with 1alpha-hydroxyvitamin D3.
Sørensen OH; Andersen RB; Christensen MS; Friis T; Hjorth L; Jørgensen FS; Lund B; Melsen F; Mosekilde L
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():169s-175s. PubMed ID: 342143
[TBL] [Abstract][Full Text] [Related]
9. 1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism.
Russell RG; Smith R; Walton RJ; Preston C; Basson R; Henderson RG; Norman AW
Lancet; 1974 Jul; 2(7871):14-7. PubMed ID: 4134407
[No Abstract] [Full Text] [Related]
10. The effect of 1alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis.
Marshall DH; Gallagher JC; Guha P; Hanes F; Oldfield W; Nordin BE
Calcif Tissue Res; 1977 May; 22 Suppl():78-84. PubMed ID: 334349
[No Abstract] [Full Text] [Related]
11. Short-term effects of 1-alpha-hydroxy-vitamin D3 in patients on corticosteroid treatment and in patients with senile osteoporosis.
Lindgren U; Lindholm S; Sarby B
Acta Med Scand; 1978; 204(1-2):89-92. PubMed ID: 685736
[TBL] [Abstract][Full Text] [Related]
12. Results of long-term treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S; Lindholm TC
Ital J Orthop Traumatol; 1984 Jun; 10(2):187-201. PubMed ID: 6432736
[TBL] [Abstract][Full Text] [Related]
13. [The effect of estrogen and, sex-steroids and thyroid hormone preparation on bone mineral density in senile osteoporosis--a comparative study of the effect of 1 alpha-hydroxycholecalciferol (1 alpha-OHD3) on senile osteoporosis].
Shiraki M; Orimo H
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):84-95. PubMed ID: 1645679
[TBL] [Abstract][Full Text] [Related]
14. Effect of fluoride therapy on nondialyzable urinary hydroxyproline, serum alkaline phosphatase, parathyroid hormone, and 25-hydroxyvitamin D.
Manzke E; Rawley R; Vose G; Roginsky M; Rader JI; Baylink DJ
Metabolism; 1977 Sep; 26(9):1005-10. PubMed ID: 895531
[No Abstract] [Full Text] [Related]
15. Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis.
Jowsey J; Riggs BL; Goldsmith RS; Kelly PJ; Arnaud CD
J Clin Endocrinol Metab; 1971 Nov; 33(5):752-8. PubMed ID: 4942159
[No Abstract] [Full Text] [Related]
16. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis.
Shiraki M; Fukuchi M; Kiriyama T; Okamoto S; Ueno T; Sakamoto H; Nagai T
J Bone Miner Metab; 2004; 22(4):352-9. PubMed ID: 15221494
[TBL] [Abstract][Full Text] [Related]
17. Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.
Pierides AM; Ellis HA; Simpson W; Dewar JH; Ward MK; Kerr DN
Lancet; 1976 May; 1(7969):1092-5. PubMed ID: 57505
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
19. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
Horowitz M; Need AG; Philcox JC; Nordin BE
Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
[TBL] [Abstract][Full Text] [Related]
20. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium.
Sørensen OH; Lund B; Saltin B; Lund B; Andersen RB; Hjorth L; Melsen F; Mosekilde L
Clin Sci (Lond); 1979 Feb; 56(2):157-61. PubMed ID: 477197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
